Literature DB >> 27115970

HIV moments and pre-exposure prophylaxis.

Robert M Grant1, David V Glidden2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27115970      PMCID： PMC6108431          DOI： 10.1016/S0140-6736(16)30125-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

3.  No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.

Authors:  Julia L Marcus; David V Glidden; Kenneth H Mayer; Albert Y Liu; Susan P Buchbinder; K Rivet Amico; Vanessa McMahan; Esper Georges Kallas; Orlando Montoya-Herrera; Jose Pilotto; Robert M Grant
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

4.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321
  4 in total
  7 in total

1.  Family planning providers' role in offering PrEP to women.

Authors:  Dominika Seidman; Shannon Weber; Kimberly Carlson; Jacki Witt
Journal:  Contraception       Date:  2018-03-09       Impact factor: 3.375

2.  Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.

Authors:  Robert M Grant; Sharon Mannheimer; James P Hughes; Yael Hirsch-Moverman; Avelino Loquere; Anupong Chitwarakorn; Marcel E Curlin; Maoji Li; K Rivet Amico; Craig W Hendrix; Peter L Anderson; Bonnie J Dye; Mark A Marzinke; Estelle Piwowar-Manning; Laura McKinstry; Vanessa Elharrar; Michael Stirratt; James F Rooney; Susan H Eshleman; Janet M McNicholl; Frits van Griensven; Timothy H Holtz
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

3.  Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men.

Authors:  Jill Blumenthal; David J Moore; Sonia Jain; Xiaoying Sun; Eric Ellorin; Katya Corado; Martin Hoenigl; Michael Dube; Richard Haubrich; Sheldon R Morris
Journal:  AIDS Patient Care STDS       Date:  2019-05       Impact factor: 5.078

4.  Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.

Authors:  Catherine A Koss; James Ayieko; Florence Mwangwa; Asiphas Owaraganise; Dalsone Kwarisiima; Laura B Balzer; Albert Plenty; Norton Sang; Jane Kabami; Theodore D Ruel; Douglas Black; Carol S Camlin; Craig R Cohen; Elizabeth A Bukusi; Tamara D Clark; Edwin D Charlebois; Maya L Petersen; Moses R Kamya; Diane V Havlir
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

5.  "I Just Decided to Stop:" Understanding PrEP Discontinuation Among Individuals Initiating PrEP in HIV Care Centers in Kenya.

Authors:  Fernandos K Ongolly; Annabel Dolla; Kenneth Ngure; Elizabeth M Irungu; Josephine Odoyo; Elizabeth Wamoni; Kathryn Peebles; Kenneth Mugwanya; Nelly R Mugo; Elizabeth A Bukusi; Jennifer Morton; Jared M Baeten; Gabrielle O'Malley
Journal:  J Acquir Immune Defic Syndr       Date:  2021-05-01       Impact factor: 3.771

Review 6.  Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.

Authors:  Erika Aaron; Cori Blum; Dominika Seidman; Mary Jo Hoyt; Joanne Simone; Meg Sullivan; Dawn K Smith
Journal:  AIDS Patient Care STDS       Date:  2018-01       Impact factor: 5.078

7.  The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.

Authors:  Paula M Luz; Benjamin Osher; Beatriz Grinsztejn; Rachel L Maclean; Elena Losina; Madeline E Stern; Claudio J Struchiner; Robert A Parker; Kenneth A Freedberg; Fabio Mesquita; Rochelle P Walensky; Valdilea G Veloso; A David Paltiel
Journal:  J Int AIDS Soc       Date:  2018-03       Impact factor: 5.396
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.